The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial. [electronic resource]
Producer: 20200420Description: 154054 p. digitalISSN:- 1532-8600
- Adult
- Aged
- Blood Glucose -- metabolism
- Combined Modality Therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Double-Blind Method
- Female
- Follow-Up Studies
- Glucose Intolerance -- drug therapy
- Glucose Tolerance Test
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin-Secreting Cells -- metabolism
- Life Style
- Linagliptin -- therapeutic use
- Male
- Metformin -- therapeutic use
- Middle Aged
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.